A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease

Overview of attention for article published in Orphanet Journal of Rare Diseases, August 2017

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 2,447 followers.

Open Access UCL Research: A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset... https://t.co/Om1BF5ULUa

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.